Covered recipient · General Payments record
ASIMA DORIWALA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2023
$323.30
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $286.59 | 13 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $64.24 | 3 |
| GlaxoSmithKline, LLC. | $45.45 | 2 |
| Lilly USA, LLC | $36.16 | 2 |
| Amgen Inc. | $28.06 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.20 | 1 |
| ABBVIE INC. | $23.48 | 1 |
| Acerta Pharma LLC | $22.32 | 1 |
| PFIZER INC. | $22.00 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $23.48 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996729433 | CMS |
| Amgen Inc. | $28.06 | 10/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019821917 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.32 | 10/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016252029 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $24.20 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000358065 | CMS |
| GlaxoSmithKline, LLC. | $15.87 | 06/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002472881 | CMS |
| GlaxoSmithKline, LLC. | $29.58 | 11/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002472957 | CMS |
| Lilly USA, LLC | $18.72 | 11/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031274923 | CMS |
| Lilly USA, LLC | $17.44 | 12/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031275099 | CMS |
| Novo Nordisk Inc | $21.60 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002711665 | CMS |
| Novo Nordisk Inc | $24.73 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002711679 | CMS |
| Novo Nordisk Inc | $17.91 | 11/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002711653 | CMS |
| PFIZER INC. | $22.00 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049301209 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.68 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056443641 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.